{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:55:52Z","timestamp":1790610952762,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s13346-026-02061-5","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T18:55:27Z","timestamp":1771959327000},"page":"3677-3701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quality by design (QbD)-guided development of PEGylated nanostructured lipid carriers of donepezil for intranasal delivery"],"prefix":"10.1007","volume":"16","author":[{"given":"Aneri","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimeet","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalitkumar K.","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"2061_CR1","doi-asserted-by":"crossref","unstructured":"Kumar A, Nisha CM, Silakari C, Sharma I, Anusha K, Gupta N, et al. Current and novel therapeutic molecules and targets in Alzheimer\u2019s disease. J Formos Med Assoc. 2016;115:3\u201310.","DOI":"10.1016\/j.jfma.2015.04.001"},{"issue":"10","key":"2061_CR2","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1517\/17425255.4.10.1363","volume":"4","author":"SA Jacobson","year":"2008","unstructured":"Jacobson SA, Sabbagh MN, Roberts C. Drug evaluation donepezil: potential neuroprotective and disease-modifying effects. Expert Opin Drug Metab Toxicol. 2008;4(10):1363\u20139.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2061_CR3","doi-asserted-by":"crossref","unstructured":"Di Stefano A, Sozio, Cerasa, Marinelli. Transdermal donepezil on the treatment of Alzheimer\u2019s disease. Neuropsychiatr Dis Treat. 2012; 8:361\u201368.","DOI":"10.2147\/NDT.S16089"},{"issue":"8","key":"2061_CR4","first-page":"1838","volume":"46","author":"M Yasir","year":"2018","unstructured":"Yasir M, Sara UVS, Chauhan I, Gaur PK, Singh AP, Puri D, et al. Solid lipid nanoparticles for nose to brain delivery of donepezil: formulation, optimization by Box-Behnken design, in vitro and in vivo evaluation. Artif Cells Nanomed Biotechnol. 2018;46(8):1838\u201351.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"5","key":"2061_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1208\/s12249-024-02810-0","volume":"25","author":"A Ghosh","year":"2024","unstructured":"Ghosh A, Majie A, Karmakar V, Chatterjee K, Chakraborty S, Pandey M, et al. In-depth mechanism, challenges, and opportunities of delivering therapeutics in brain using intranasal route. AAPS PharmSciTech. 2024;25(5):96.","journal-title":"AAPS PharmSciTech"},{"key":"2061_CR6","doi-asserted-by":"crossref","unstructured":"Polaka S, Desai N, Kshirsagar B, Rajpoot K, Tekade RK. Revamping the pharmacokinetics of poorly soluble drugs using different formulations. In: Biopharmaceutics and Pharmacokinetics Considerations. 2021. pp 387\u2013413.","DOI":"10.1016\/B978-0-12-814425-1.00005-X"},{"key":"2061_CR7","doi-asserted-by":"crossref","unstructured":"Bhavna, Md S, Ali M, Ali R, Bhatnagar A, Baboota S et al. Donepezil nanosuspension intended for nose-to-brain targeting: In vitro and in vivo safety evaluation. Int J Biol Macromol. 2014;67:418\u201325.","DOI":"10.1016\/j.ijbiomac.2014.03.022"},{"issue":"2","key":"2061_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/pharmaceutics11020064","volume":"11","author":"LC Espinoza","year":"2019","unstructured":"Espinoza LC, Silva-Abreu M, Clares B, Rodriguez-Lagunas MJ, Halbaut L, Canas MA, et al. Formulation strategies to improve nose-to-brain delivery of donepezil. Pharmaceutics. 2019;11(2):64.","journal-title":"Pharmaceutics"},{"issue":"1","key":"2061_CR9","first-page":"1","volume":"13","author":"GR Topal","year":"2021","unstructured":"Topal GR, Meszaros M, Porkolab G, Szecsko A, Polgar TF, Siklos L, et al. ApoE-targeting increases the transfer of solid lipid nanoparticles with donepezil cargo across a culture model of the blood\u2013brain barrier. Pharmaceutics. 2021;13(1):1\u201319.","journal-title":"Pharmaceutics"},{"key":"2061_CR10","doi-asserted-by":"crossref","unstructured":"de Oliveira Junior ER, Santos LCR, Salomao MA, Nascimento TL, de Almeida Ribeiro Oliveira G, Liao LM, et al. Nose-to-brain drug delivery mediated by polymeric nanoparticles: influence of PEG surface coating. Drug Deliv Transl Res. 2020;10(6):1688\u201399.","DOI":"10.1007\/s13346-020-00816-2"},{"issue":"7","key":"2061_CR11","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s40263-022-00930-4","volume":"36","author":"A Lofts","year":"2022","unstructured":"Lofts A, Abu-Hijleh F, Rigg N, Mishra RK, Hoare T. Using the intranasal route to administer drugs to treat neurological and psychiatric illnesses: rationale, successes, and future needs. CNS Drugs. 2022;36(7):739\u201370.","journal-title":"CNS Drugs"},{"key":"2061_CR12","doi-asserted-by":"publisher","unstructured":"Alavi SE, Urooj B, Maedeh Koohi ME, Hossein A, Seyed HA, Hasan ES, Aun R. A PEGylated nanostructured lipid carrier for enhanced oral delivery of antibiotics. Pharmaceutics. 2022;14(8):1668. https:\/\/doi.org\/10.3390\/pharmaceutics14081668.","DOI":"10.3390\/pharmaceutics14081668"},{"key":"2061_CR13","doi-asserted-by":"crossref","unstructured":"Pourmadadi M, Abad FRA, Rahdar A, Pandey S. Multifunctional nanocarrier systems for ampicillin delivery: comparative insights into polymer, lipid, mineral, and carbon-based platforms. J Drug Deliv Sci Technol. 2026;115(1):107698. Editions de Sante.","DOI":"10.1016\/j.jddst.2025.107698"},{"key":"2061_CR14","doi-asserted-by":"publisher","first-page":"107208","DOI":"10.1016\/j.jddst.2025.107208","volume":"111","author":"M Shirzad","year":"2025","unstructured":"Shirzad M, Salahvarzi A, Fathi-karkan S, Rahdar A, Guettari M, Pandey S. Green nanocarriers and biodegradable systems for sustainable drug delivery solutions. J Drug Deliv Sci Technol. 2025;111:107208.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2061_CR15","doi-asserted-by":"publisher","unstructured":"Hallajisani M, Mehrab P, Fatemeh Y, Hamid R, Abbas R, Sadanand P. Next-gen aspirin: Smart nanocarriers for targeted and controlled therapeutic delivery. J Drug Deliv Sci Technol. 2025;107664.\u00a0https:\/\/doi.org\/10.1016\/j.jddst.2025.107664.","DOI":"10.1016\/j.jddst.2025.107664"},{"issue":"5","key":"2061_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1208\/s12249-025-03103-w","volume":"26","author":"N Patel","year":"2025","unstructured":"Patel N, Desai A, Vyas B, Shah P, Shubhada M, Milind U, et al. Integration of synchronizing in silico, in vitro, and in vivo strategies for the development of antipsoriatic apremilast-loaded nanostructured lipid carrier embedded in hydrogel. AAPS PharmSciTech. 2025;26(5):115.","journal-title":"AAPS PharmSciTech"},{"key":"2061_CR17","doi-asserted-by":"crossref","unstructured":"Selvaraj K, Gowthamarajan K, Karri VVSR. Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting. Artif Cells Nanomed Biotechnol. 2017;28:1\u20138.","DOI":"10.1080\/21691401.2017.1420073"},{"issue":"3","key":"2061_CR18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/pharmaceutics14030572","volume":"14","author":"TTL Nguyen","year":"2022","unstructured":"Nguyen TTL, Maeng HJ. Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery. Pharmaceutics. 2022;14(3):572.","journal-title":"Pharmaceutics"},{"key":"2061_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114266","volume":"198","author":"M Ongun","year":"2024","unstructured":"Ongun M, Lokras AG, Baghel S, Shi Z, Schmidt ST, Franzyk H, et al. Lipid nanoparticles for local delivery of mRNA to the respiratory tract: effect of PEG-lipid content and administration route. Eur J Pharm Biopharm. 2024;198: 114266.","journal-title":"Eur J Pharm Biopharm"},{"issue":"11","key":"2061_CR20","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.3390\/pharmaceutics16111423","volume":"16","author":"M Li","year":"2024","unstructured":"Li M, Yi J, Lu Y, Liu T, Xing H, Wang X, et al. Modified PEG-lipids enhance the nasal mucosal immune capacity of lipid nanoparticle mRNA vaccines. Pharmaceutics. 2024;16(11):1423.","journal-title":"Pharmaceutics"},{"key":"2061_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125166","volume":"670","author":"A Bazargani","year":"2025","unstructured":"Bazargani A, Hejazi M, Fernandez M, Cordeiro A, Tsala Ebode J, Lewinski N, et al. PEGylated solid lipid nanoparticles for the intranasal delivery of combination antiretroviral therapy composed of Atazanavir and Elvitegravir to treat NeuroAIDS. Int J Pharm. 2025;670: 125166.","journal-title":"Int J Pharm"},{"key":"2061_CR22","doi-asserted-by":"publisher","unstructured":"Maniyamgama N, Ki HB, Zi WC, Jialing L, Melgious JYA, Yong JT, Lisa FP Ng, Laurent R, Kevin P, White, Yi YY. Muco Penetrating Lipid Nanoparticles Having a Liquid Core for Enhanced Intranasal mRNA Delivery. Adv Sci. 2025;12(11):2407383. https:\/\/doi.org\/10.1002\/advs.202407383.","DOI":"10.1002\/advs.202407383"},{"issue":"7","key":"2061_CR23","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3109\/03639045.2014.938082","volume":"41","author":"L Wang","year":"2015","unstructured":"Wang L, Luo Q, Lin T, Li R, Zhu T, Zhou K, et al. PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A. Drug Dev Ind Pharm. 2015;41(7):1204\u201312.","journal-title":"Drug Dev Ind Pharm"},{"key":"2061_CR24","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.2147\/IJN.S439181","volume":"19","author":"J Koo","year":"2024","unstructured":"Koo J, Lim C, Oh KT. Recent advances in intranasal administration for brain-targeting delivery: a comprehensive review of lipid-based nanoparticles and stimuli-responsive gel formulations. Int J Nanomedicine. 2024;19:1767\u2013807 Dove Medical Press Ltd.","journal-title":"Int J Nanomedicine"},{"key":"2061_CR25","doi-asserted-by":"publisher","unstructured":"Ben Mihoub A, Kamil E, Janske N, Samir A, Emilie V, Catherine M, Michel L et al. Neuroprotective effect of curcumin-loaded RGD peptide-PEGylated nanoliposomes. Pharmaceutics. 2023;15(12):2665. https:\/\/doi.org\/10.3390\/pharmaceutics15122665.","DOI":"10.3390\/pharmaceutics15122665"},{"issue":"8","key":"2061_CR26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/17425247.2018.1504768","volume":"15","author":"V Mishra","year":"2018","unstructured":"Mishra V, Thakur S, Patil A, Shukla A. Quality by design (QbD) approaches in current pharmaceutical set-up. Expert Opin Drug Deliv. 2018;15(8):737\u201358.","journal-title":"Expert Opin Drug Deliv"},{"issue":"5","key":"2061_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/pharmaceutics17050623","volume":"17","author":"S Yang","year":"2025","unstructured":"Yang S, Hu X, Zhu J, Zheng B, Bi W, Wang X, et al. Aspects and implementation of pharmaceutical quality by design from conceptual frameworks to industrial applications. Pharmaceutics. 2025;17(5):623.","journal-title":"Pharmaceutics"},{"issue":"12","key":"2061_CR28","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1080\/17425247.2023.2274902","volume":"20","author":"AC Correia","year":"2023","unstructured":"Correia AC, Moreira JN, Sousa Lobo JM, Silva AC. Design of experiment (DoE) as a quality by design (QbD) tool to optimise formulations of lipid nanoparticles for nose-to-brain drug delivery. Expert Opin Drug Deliv. 2023;20(12):1731\u201348.","journal-title":"Expert Opin Drug Deliv"},{"key":"2061_CR29","first-page":"100266","volume":"8","author":"AB Buya","year":"2024","unstructured":"Buya AB, Mahlangu P, Witika BA. From lab to industrial development of lipid nanocarriers using quality by design approach. International Journal of Pharmaceutics: X. 2024;8:100266.","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"1","key":"2061_CR30","doi-asserted-by":"publisher","first-page":"100142","DOI":"10.1016\/j.nexres.2025.100142","volume":"2","author":"P Patel","year":"2025","unstructured":"Patel P, Trivedi A, Prajapati BG, Kapoor DU. QbD- driven development and characterization of Lactoferrin-loaded nanoparticles in in-situ gel for treating postmenopausal osteoporosis. Next Research. 2025;2(1):100142.","journal-title":"Next Research"},{"issue":"5","key":"2061_CR31","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1007\/s13346-020-00803-7","volume":"10","author":"N Rangaraj","year":"2020","unstructured":"Rangaraj N, Pailla SR, Shah S, Prajapati S, Sampathi S. QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomicron flow blocking approach. Drug Deliv Transl Res. 2020;10(5):1476\u201394.","journal-title":"Drug Deliv Transl Res"},{"issue":"6","key":"2061_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/20415990.2024.2342771","volume":"15","author":"HP Nijhawan","year":"2024","unstructured":"Nijhawan HP, Prabhakar B, Yadav KS. Central composite design augmented quality-by-design-based systematic formulation of erlotinib hydrochloride-loaded chitosan-poly (lactic-co-glycolic acid) nanoparticles. Ther Deliv. 2024;15(6):427\u201347.","journal-title":"Ther Deliv"},{"issue":"1","key":"2061_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/1871527317666180104122347","volume":"17","author":"LC Espinoza","year":"2018","unstructured":"Espinoza LC, Vacacela M, Clares B, Garcia ML, Fabrega MJ, Calpena AC. Development of a nasal donepezil-loaded microemulsion for the treatment of alzheimer\u2019s disease: in vitro and ex vivo characterization. CNS Neurol Disord Drug Targets. 2018;17(1):43\u201353.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"2061_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1208\/s12249-019-1585-7","volume":"21","author":"D Khunt","year":"2020","unstructured":"Khunt D, Shrivas M, Polaka S, Gondaliya P, Misra M. Role of omega-3 fatty acids and butter oil in targeting delivery of donepezil hydrochloride microemulsion to brain via the intranasal route: a comparative study. AAPS PharmSciTech. 2020;21(2):45.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"2061_CR35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s12247-022-09636-y","volume":"18","author":"A Gangopadhyay","year":"2023","unstructured":"Gangopadhyay A, Dandagi PM, Sutar KP. Development and evaluation of thermoreversible ethosomal gel of donepezil hydrochloride for intranasal delivery. J Pharm Innov. 2023;18(1):238\u201346.","journal-title":"J Pharm Innov"},{"issue":"1","key":"2061_CR36","doi-asserted-by":"publisher","first-page":"9563","DOI":"10.1038\/s41598-019-46032-y","volume":"9","author":"S Al Harthi","year":"2019","unstructured":"Al Harthi S, Alavi SE, Radwan MA, El Khatib MM, AlSarra IA. Nasal delivery of donepezil HCl-loaded hydrogels for the treatment of Alzheimer\u2019s disease. Sci Rep. 2019;9(1):9563.","journal-title":"Sci Rep"},{"issue":"13","key":"2061_CR37","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.3390\/molecules25132991","volume":"25","author":"D Santonocito","year":"2020","unstructured":"Santonocito D, Sarpietro MG, Carbone C, Panico A, Campisi A, Siciliano EA, et al. Curcumin containing PEGylated solid lipid nanoparticles for systemic administration: a preliminary study. Molecules. 2020;25(13):2991.","journal-title":"Molecules"},{"key":"2061_CR38","doi-asserted-by":"publisher","first-page":"104571","DOI":"10.1016\/j.jddst.2023.104571","volume":"86","author":"P Verma","year":"2023","unstructured":"Verma P, Yadav KS. Quality by design (QbD) enabled and Box-Behnken design assisted approach for formulation of tranexamic acid loaded stratum corneum lipid liposomes. J Drug Deliv Sci Technol. 2023;86:104571.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2061_CR39","doi-asserted-by":"publisher","first-page":"102206","DOI":"10.1016\/j.nano.2020.102206","volume":"28","author":"S Cunha","year":"2020","unstructured":"Cunha S, Costa CP, Moreira JN, Sousa Lobo JM, Silva AC. Using the quality by design (QbD) approach to optimize formulations of lipid nanoparticles and nanoemulsions: a review. Nanomedicine. 2020;28:102206.","journal-title":"Nanomedicine"},{"issue":"5","key":"2061_CR40","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1080\/21691401.2016.1200057","volume":"45","author":"AK Sahu","year":"2017","unstructured":"Sahu AK, Jain V. Screening of process variables using Plackett-Burman design in the fabrication of gedunin-loaded liposomes. Artif Cells Nanomed Biotechnol. 2017;45(5):1011\u201322.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"2061_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2024.124731","volume":"321","author":"P Prajapati","year":"2024","unstructured":"Prajapati P, Patel A, Desai A, Shah P, Pulusu VS, Haque A, et al. In-vivo pharmacokinetic study of ibrutinib-loaded nanostructured lipid carriers in rat plasma by sensitive spectrofluorimetric method using harmonized approach of quality by design and white analytical chemistry. Spectrochim Acta A Mol Biomol Spectrosc. 2024;321: 124731.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"2061_CR42","doi-asserted-by":"publisher","first-page":"111468","DOI":"10.1016\/j.molliq.2019.111468","volume":"293","author":"F Pinto","year":"2019","unstructured":"Pinto F, de Barros DPC, Reis C, Fonseca LP. Optimization of nanostructured lipid carriers loaded with retinoids by central composite design. J Mol Liq. 2019;293:111468.","journal-title":"J Mol Liq"},{"issue":"2","key":"2061_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/22297928.2024.2331143","volume":"14","author":"S Jamadar","year":"2024","unstructured":"Jamadar S, Rao GK. Optimizing clozapine-loaded nanostructured lipid carriers through central composite design for enhance bioavailability in antipsychotic therapy. Analytical Chemistry Letters. 2024;14(2):143\u201357.","journal-title":"Analytical Chemistry Letters"},{"issue":"3","key":"2061_CR44","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3390\/ma16031212","volume":"16","author":"I Andreana","year":"2023","unstructured":"Andreana I, Bincoletto V, Manzoli M, Rod\u00e0 F, Giarraputo V, Milla P, et al. Freeze drying of polymer nanoparticles and liposomes exploiting different saccharide-based approaches. Materials. 2023;16(3):1212.","journal-title":"Materials"},{"issue":"3","key":"2061_CR45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/jnt5030008","volume":"5","author":"A Nadkarni","year":"2024","unstructured":"Nadkarni A, Rana D, Desai N, Benival D, Joshi V, Salave S, et al. Advanced characterization and sample preparation strategies for nanoformulations. Journal of Nanotheranostics. 2024;5(3):104\u201327.","journal-title":"Journal of Nanotheranostics"},{"key":"2061_CR46","doi-asserted-by":"crossref","unstructured":"Agrawal M, Saraf S, Pradhan M, Patel RJ, Singhvi G, Ajazuddin, et al. Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design. Biomed Pharmacother. 2021; 141:111919.","DOI":"10.1016\/j.biopha.2021.111919"},{"key":"2061_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.colsurfb.2017.03.006","volume":"154","author":"V Kaithwas","year":"2017","unstructured":"Kaithwas V, Dora CP, Kushwah V, Jain S. Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability. Colloids Surf B Biointerfaces. 2017;154:10\u201320.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2061_CR48","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2147\/IJN.S151474","volume":"13","author":"Q Meng","year":"2018","unstructured":"Meng Q, Wang A, Hua H, Jiang Y, Wang Y, Mu H, et al. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer & rsquos disease. Int J Nanomedicine. 2018;13:705\u201318.","journal-title":"Int J Nanomedicine"},{"key":"2061_CR49","doi-asserted-by":"publisher","first-page":"100120","DOI":"10.1016\/j.jciso.2024.100120","volume":"15","author":"LS Viswanadha","year":"2024","unstructured":"Viswanadha LS, Arcot Y, Lin YT, Akbulut MES. A comparative investigation of release kinetics of paclitaxel from natural protein and macromolecular nanocarriers in nanoscale drug delivery systems. JCIS Open. 2024;15:100120.","journal-title":"JCIS Open"},{"key":"2061_CR50","doi-asserted-by":"publisher","unstructured":"Prajapati P, Krishna P, Pranav S, Vilas S, Anzarul H, Mohd AK, Shailesh S. An eco\u2010friendly and sensitive microwave\u2010aided spectrofluorophotometric characterization of mirabegron\u2010loaded nanocarriers by amalgamation of design of experiments and white analytical chemistry. Luminescence. 2024;39(12):e70046. https:\/\/doi.org\/10.1002\/bio.70046.","DOI":"10.1002\/bio.70046"},{"key":"2061_CR51","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.2147\/IJN.S258791","volume":"15","author":"UA Fahmy","year":"2020","unstructured":"Fahmy UA, Ahmed OA, Badr-Eldin SM, Aldawsari HM, Okbazghi SZ, Awan ZA, et al. Optimized nanostructured lipid carriers integrated into In Situ Nasal Gel for Enhancing Brain Delivery of flibanserin. Int J Nanomedicine. 2020;15:5253\u201364.","journal-title":"Int J Nanomedicine"},{"key":"2061_CR52","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH Harmonised Tripartite Guideline: stability testing of new drug substances and products Q1A(R2). Geneva, Switzerland; 2003. https:\/\/database.ich.org\/sites\/default\/files\/Q1A%28R2%29%20Guideline.pdf."},{"key":"2061_CR53","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ejps.2016.12.020","volume":"99","author":"A Kovacs","year":"2017","unstructured":"Kovacs A, Berko Sz, Csanyi E, Csoka I. Development of nanostructured lipid carriers containing salicyclic acid for dermal use based on the quality by design method. Eur J Pharm Sci. 2017;99:246\u201357.","journal-title":"Eur J Pharm Sci"},{"issue":"40","key":"2061_CR54","doi-asserted-by":"publisher","first-page":"101378","DOI":"10.1016\/j.nanoso.2024.101378","volume":"1","author":"P Patel","year":"2024","unstructured":"Patel P, Thanki A, Kapoor DU, Prajapati BG. QbD decorated ellagic acid loaded polymeric nanoparticles: Factors influencing desolvation method and preliminary evaluations. Nano-Structures and Nano-Objects. 2024;1(40):101378.","journal-title":"Nano-Structures and Nano-Objects"},{"issue":"7","key":"2061_CR55","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1208\/s12249-022-02386-7","volume":"23","author":"N Bajwa","year":"2022","unstructured":"Bajwa N, Mahal S, Naryal S, Singh PA, Baldi A. Development of novel solid nanostructured lipid carriers for bioavailability enhancement using a quality by design approach. AAPS PharmSciTech. 2022;23(7):253.","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"2061_CR56","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s13346-021-01083-5","volume":"12","author":"VC Gurumukhi","year":"2022","unstructured":"Gurumukhi VC, Bari SB. Development of ritonavir-loaded nanostructured lipid carriers employing quality by design (QbD) as a tool: characterizations, permeability, and bioavailability studies. Drug Deliv Transl Res. 2022;12(7):1753\u201373.","journal-title":"Drug Deliv Transl Res"},{"issue":"6","key":"2061_CR57","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3390\/pharmaceutics16060691","volume":"16","author":"M Mukhtar","year":"2024","unstructured":"Mukhtar M, Csoka I, Martinovic J, Selo G, Bucic-Kojic A, Orosz L, et al. Fabrication of ciprofloxacin-loaded sodium alginate nanobeads coated with thiol-anchored chitosan using b-390 encapsulator following optimization by DoE. Pharmaceutics. 2024;16(6):691.","journal-title":"Pharmaceutics"},{"issue":"1","key":"2061_CR58","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s12668-024-01624-5","volume":"15","author":"P Patel","year":"2025","unstructured":"Patel P, Vaidya R, Kansara Y, Shah P, Kapoor DU, Prajapati BG. Multivariate optimization of carbamazepine-loaded nanostructured lipid carriers for brain targeting and epilepsy management. Bionanoscience. 2025;15(1):156.","journal-title":"Bionanoscience"},{"issue":"3","key":"2061_CR59","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3109\/10837450.2012.659256","volume":"18","author":"L Keshri","year":"2013","unstructured":"Keshri L, Pathak K. Development of thermodynamically stable nanostructured lipid carrier system using central composite design for zero order permeation of Econazole nitrate through epidermis. Pharm Dev Technol. 2013;18(3):634\u201344.","journal-title":"Pharm Dev Technol"},{"issue":"1","key":"2061_CR60","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3109\/10717544.2014.903011","volume":"23","author":"C Puglia","year":"2016","unstructured":"Puglia C, Offerta A, Tirendi GG, Tarico MS, Curreri S, Bonina F, et al. Design of solid lipid nanoparticles for caffeine topical administration. Drug Deliv. 2016;23(1):36\u201340.","journal-title":"Drug Deliv"},{"issue":"1\u20132","key":"2061_CR61","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijpharm.2010.12.036","volume":"406","author":"A Kovacevic","year":"2011","unstructured":"Kovacevic A, Savic S, Vuleta G, M\u00fcller RH, Keck CM. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability, and particle matrix structure. Int J Pharm. 2011;406(1\u20132):163\u201372.","journal-title":"Int J Pharm"},{"key":"2061_CR62","doi-asserted-by":"publisher","first-page":"101775","DOI":"10.1016\/j.jddst.2020.101775","volume":"57","author":"A Qadir","year":"2020","unstructured":"Qadir A, Aqil M, Ali A, Warsi MH, Mujeeb M, Ahmad FJ, et al. Nanostructured lipidic carriers for dual drug delivery in the management of psoriasis: systematic optimization, dermatokinetic and preclinical evaluation. J Drug Deliv Sci Technol. 2020;57:101775.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"4","key":"2061_CR63","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/pharmaceutics13040437","volume":"13","author":"P Mura","year":"2021","unstructured":"Mura P, Maestrelli F, D\u2019Ambrosio M, Luceri C, Cirri M. Evaluation and Comparison of Solid lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as vectors to develop hydrochlorothiazide effective and safe pediatric oral liquid formulations. Pharmaceutics. 2021;13(4):437.","journal-title":"Pharmaceutics"},{"issue":"29","key":"2061_CR64","doi-asserted-by":"publisher","first-page":"8415","DOI":"10.1002\/slct.201800855","volume":"3","author":"SF Sousa","year":"2018","unstructured":"Sousa SF, Peres J, Coelho M, Vieira TF. Analyzing PEGylation through molecular dynamics simulations. ChemistrySelect. 2018;3(29):8415\u201327.","journal-title":"ChemistrySelect"},{"key":"2061_CR65","doi-asserted-by":"publisher","first-page":"118771","DOI":"10.1016\/j.ijpharm.2019.118771","volume":"572","author":"P Lakhani","year":"2019","unstructured":"Lakhani P, Patil A, Wu KW, Sweeney C, Tripathi S, Avula B, et al. Optimization, stabilization, and characterization of amphotericin B-loaded nanostructured lipid carriers for ocular drug delivery. Int J Pharm. 2019;572:118771.","journal-title":"Int J Pharm"},{"key":"2061_CR66","doi-asserted-by":"crossref","unstructured":"Pochapski DJ, Carvalho dos Santos C, Leite GW, Pulcinelli SH, Santilli CV. Zeta Potential and Colloidal Stability Predictions for Inorganic Nanoparticle Dispersions: Effects of Experimental Conditions and Electrokinetic Models on the Interpretation of Results. Langmuir. 2021;37(45):13379\u201389.","DOI":"10.1021\/acs.langmuir.1c02056"},{"key":"2061_CR67","first-page":"100074","volume":"3","author":"G Shadambikar","year":"2021","unstructured":"Shadambikar G, Marathe S, Ji N, Almutairi M, Bandari S, Zhang F, et al. Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology. Int J Pharm X. 2021;3:100074.","journal-title":"Int J Pharm X"},{"key":"2061_CR68","doi-asserted-by":"publisher","first-page":"137967","DOI":"10.1016\/j.jcis.2025.137967","volume":"697","author":"JE Campos Pacheco","year":"2025","unstructured":"Campos Pacheco JE, Vitali A, Falkman P, Marauri A, Marches A, Al-Najjar H, et al. Bioinspired lipid coated porous particle as an inhalable carrier with pulmonary surfactant adhesion and mucus penetration. J Colloid Interface Sci. 2025;697:137967.","journal-title":"J Colloid Interface Sci"},{"key":"2061_CR69","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.colsurfb.2019.02.007","volume":"177","author":"IT Mendes","year":"2019","unstructured":"Mendes IT, Ruela ALM, Carvalho FC, Freitas JTJ, Bonfilio R, Pereira GR. Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil. Colloids Surf B Biointerfaces. 2019;177:274\u201381.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"11","key":"2061_CR70","doi-asserted-by":"publisher","first-page":"1168408","DOI":"10.3389\/fbioe.2023.1168408","volume":"27","author":"L Li","year":"2023","unstructured":"Li L, Tan L, Zhang Q, Cheng Y, Liu Y, Li R, et al. Nose-to-brain delivery of self-assembled curcumin-lactoferrin nanoparticles: Characterization, neuroprotective effect and in vivo pharmacokinetic study. Front Bioeng Biotechnol. 2023;27(11):1168408.","journal-title":"Front Bioeng Biotechnol"},{"issue":"7","key":"2061_CR71","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1208\/s12249-020-01810-0","volume":"21","author":"S Mahmood","year":"2020","unstructured":"Mahmood S, Kiong KC, Tham CS, Chien TC, Hilles AR, Venugopal JR. PEGylated lipid polymeric nanoparticle-encapsulated acyclovir for in vitro controlled release and ex vivo gut sac permeation. AAPS PharmSciTech. 2020;21(7):285.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"2061_CR72","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/bdd.2348","volume":"44","author":"AH Pheiffer","year":"2023","unstructured":"Pheiffer AH, Van Niekerk S, Kooy FV, Cloete T, Steenekamp J, Hamman J. In vitro and ex vivo experimental models for evaluation of intranasal systemic drug delivery as well as direct nose-to-brain drug delivery. Biopharm Drug Dispos. 2023;44(1):94\u2013112.","journal-title":"Biopharm Drug Dispos"},{"issue":"7","key":"2061_CR73","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.3390\/pharmaceutics15071985","volume":"15","author":"D Mohanty","year":"2023","unstructured":"Mohanty D, Alsaidan OA, Zafar A, Dodle T, Gupta JK, Yasir M, et al. Development of atomoxetine-loaded nlc in situ gel for nose-to-brain delivery: optimization, in vitro, and preclinical evaluation. Pharmaceutics. 2023;15(7):1985.","journal-title":"Pharmaceutics"},{"issue":"9","key":"2061_CR74","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","volume":"9","author":"Q Xu","year":"2015","unstructured":"Xu Q, Ensign LM, Boylan NJ, Sch\u00f6n A, Gong X, Yang JC, et al. Impact of Surface Polyethylene Glycol (PEG) density on biodegradable nanoparticle transport in Mucus ex Vivo and Distribution in Vivo. ACS Nano. 2015;9(9):9217\u201327.","journal-title":"ACS Nano"},{"issue":"1","key":"2061_CR75","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1039\/D3NH00306J","volume":"9","author":"A Khalil","year":"2024","unstructured":"Khalil A, Barras A, Boukherroub R, Tseng CL, Devos D, Burnouf T, et al. Enhancing paracellular and transcellular permeability using nanotechnological approaches for the treatment of brain and retinal diseases. Nanoscale Horiz. 2024;9(1):14\u201343.","journal-title":"Nanoscale Horiz"},{"key":"2061_CR76","doi-asserted-by":"crossref","unstructured":"Jojo GM, Kuppusamy G, De A, Karri VVSNR. Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer\u2019s disease using Box-Behnken design. Drug Dev Ind Pharm. 2019;45(7):1061\u201372.","DOI":"10.1080\/03639045.2019.1593439"},{"issue":"9","key":"2061_CR77","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1080\/00914037.2022.2052728","volume":"72","author":"D Patil","year":"2023","unstructured":"Patil D, Nangare S, Patil G, Nerkar K, Patil G. Development of thiolated polyethylene glycol-poly (lactic-co-glycolic acid) co-polymeric nanoparticles for intranasal delivery of quetiapine: in vitro \u2013 ex vivo characterization. Int J Polym Mater Polym Biomater. 2023;72(9):714\u201324.","journal-title":"Int J Polym Mater Polym Biomater"},{"key":"2061_CR78","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2147\/IJN.S402447","volume":"18","author":"MK Shehata","year":"2023","unstructured":"Shehata MK, Ismail AA, Kamel MA. Nose to brain delivery of astaxanthin\u2013loaded nanostructured lipid carriers in rat model of Alzheimer\u2019s disease: preparation, in vitro and in vivo evaluation. Int J Nanomedicine. 2023;18:1631\u201358.","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"2061_CR79","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/pharmaceutics11020097","volume":"11","author":"AA Khan","year":"2019","unstructured":"Khan AA, Mudassir J, Akhtar S, Murugaiyah V, Darwis Y. Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations. Pharmaceutics. 2019;11(2):97.","journal-title":"Pharmaceutics"},{"key":"2061_CR80","first-page":"103631.81","volume":"75","author":"M Yasir","year":"2022","unstructured":"Yasir M, Zafar A, Noorulla KM, Tura AJ, Sara UVS, Panjwani D, et al. Nose to brain delivery of donepezil through surface-modified NLCs: Formulation development, optimization, and brain targeting study. J Drug Deliv Sci Technol. 2022;75:103631.81.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"9","key":"2061_CR81","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1080\/03639045.2023.2262035","volume":"49","author":"AR Tekade","year":"2023","unstructured":"Tekade AR, Suryavanshi MR, Shewale AB, Patil VS. Design and development of donepezil hydrochloride-loaded nanostructured lipid carriers for efficient management of Alzheimer\u2019s disease. Drug Dev Ind Pharm. 2023;49(9):590\u2013600.","journal-title":"Drug Dev Ind Pharm"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02061-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02061-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02061-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:03:17Z","timestamp":1790607797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02061-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":81,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2061"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02061-5","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research did not involve the use of human subjects or animals.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical Trial Registration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and provided consent for the publication of the research manuscript.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}